Benzinga | Aug 11, 2021 06:09AM EDT

Haemonetics Q1 Adj. EPS $0.50 Beats $0.46 Estimate, Sales $229.00M Beat $219.35M Estimate; Raises FY22 Guidance For Vascular Closure Sales

Haemonetics (NYSE:HAE) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.46 by 8.7 percent. This is a 8.7 percent increase over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $229.00 million which beat the analyst consensus estimate of $219.35 million by 4.40 percent. This is a 17.09 percent increase over sales of $195.58 million the same period last year.